文献速递药物不良反应与药物警戒

疫苗犹豫对自报不良事件发生、严重程度及类型的影响:法国横断面调查

Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey.
PubMed 文献 · Drug Saf · 2022-08-16

该研究基于2021年法国18岁以上代表性人群的横断面在线调查(n=1593),由药物安全与药物警戒专家对自报不良事件进行分类分析。结果显示,自报不良事件比例从非犹豫者的18%升至非常犹豫者的65%,严重程度从5%升至41%,且各组不良事件特征相似;多因素回归中年轻和女性与更高的报告率相关。结论提示疫苗犹豫可能是患者自报疫苗相关不良事件及其感知严重程度的重要驱动因素,接种者应关注犹豫患者并告知可能的反安慰剂效应。

要点

  • 疫苗犹豫程度越高,自报不良事件比例越高(18%至65%)。
  • 感知严重程度亦随犹豫程度升高(5%至41%)。
  • 各组不良事件特征相似,提示可能存在反安慰剂效应。

核心结论

  • 疫苗犹豫可能是患者自报疫苗相关不良事件及其感知严重程度的重要驱动因素。
  • 接种者应特别关注犹豫患者,并告知这些不良事件可能的反安慰剂性质以加以预防。

研究设计与样本

  • 2021年法国18岁及以上代表性人群的横断面在线调查,样本量n=1593。
  • 所有报告的不良事件由药物安全与药物警戒领域的受训专家进行分析和分类。
  • 采用多因素二项回归分析自报不良事件的发生、疫苗犹豫类别及预设的应答者特征。

主要发现

  • 590名(37.0%)参与者报告至少一种不良事件,其中121名(20.5%)认为属于严重。
  • 自报不良事件比例从非犹豫者的18%到非常犹豫者的65%不等。
  • 感知严重程度从非犹豫者的5%到非常犹豫者的41%不等。
  • 各组之间不良事件特征保持相似。
  • 多因素回归模型中,除疫苗接种态度外,较年轻年龄和女性与更高的疫苗不良事件报告显著相关。

临床怎么用

  • 接种者在面对犹豫患者时应特别关注其不良事件报告与感知严重程度。
  • 可向犹豫患者说明所报告不良事件可能的反安慰剂性质,以帮助预防此类事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Little is known about the impact of mandatory vaccination on people who are reluctant to be vaccinated, despite the potential importance in terms of public health policy. OBJECTIVE: We aimed to explore the relationship between vaccine hesitancy and onset, severity and characteristics of self-reported adverse events. METHODS: We used a cross-sectional online survey conducted in 2021 among a representative sample of the French population aged 18 years and older (n = 1593). All reported adverse events were analyzed and categorized by trained experts in drug safety and pharmacovigilance. Multivariate binomial regressions on the onset of self-reported adverse events, vaccine hesitancy categories and predefined responders' characteristics were performed. RESULTS: Overall, 590 (37.0%) participants reported at least one adverse event, with 121 (20.5%) considered it to be severe. Proportions of reported adverse events, ranging from 18% (in non-reluctant responders) to 65% (in very reluctant responders), and their severity, ranging from 5% (non-reluctant responders) to 41% (very reluctant responders), depended highly on attitudes toward vaccination. The adverse events profile remained similar between groups. In the multivariate regression model, beyond attitude toward vaccination, younger age and female gender were significantly associated with higher reporting of vaccine adverse events. CONCLUSIONS: Our results suggest that vaccine hesitancy could be a major driver of patient-reported vaccine-related adverse events and their perceived severity. In this context, vaccinators must pay special attention to reluctant patients and inform them on the possible nocebo nature of these adverse events so as to prevent them.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Khouri C, Larabi A, Verger P, et al. Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey. Drug Saf. 2022. PMID: 35972651. doi:10.1007/s40264-022-01220-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。